未登录

S

Swan Swan Leong

national cancer centre singapore (nccs)

H指数:21

被引数:2,317

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase II study evaluating the safety and efficacy of an adenovirus-DLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma

评估adenovirus-DLMP1-LMP2转导的树突状细胞疫苗在晚期转移性鼻咽癌患者中的安全性和有效性的II期研究

ANNALS OF ONCOLOGY

IF65.4

2012-04-01123

OAAI

Female Reproductive Factors, Gene Polymorphisms in the Estrogen Metabolism Pathway, and Risk of Lung Cancer in Chinese Women

AMERICAN JOURNAL OF EPIDEMIOLOGY

IF4.8

2012-02-1341

OAAI

Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma

ANNALS OF ONCOLOGY

IF65.4

2011-03-0167

OAAI

Polymorphisms in inflammatory pathway genes, host factors and lung cancer risk in Chinese female never-smokers

IF2.9

2011-01-2055

OAAI

Impact of comorbidities on clinical outcomes in non-small cell lung cancer patients who are elderly and/or have poor performance status

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

IF5.6

2010-10-0122

PREAI

Lung Cancer in Chinese Women: Evidence for an Interaction between Tobacco Smoking and Exposure to Inhalants in the Indoor Environment

ENVIRONMENTAL HEALTH PERSPECTIVES

IF9.8

2010-09-0150

OAAI

Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol®-PM) in patients with solid tumors

每周脂质体紫杉醇制剂的I期药代动力学研究 (Genexol®-PM) 在实体瘤患者中

ANNALS OF ONCOLOGY

IF65.4

2010-02-01145

OAAI

Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma

IF5.1

2008-07-0962

PREAI

A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells

INVESTIGATIONAL NEW DRUGS

IF2.7

2007-09-12160

PREAI

Intensity modulated radiotherapy (IMRT) in the salvage of recurrent nasopharyngeal carcinoma

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2006-11-010

PREAI

Final report of SQNP01 - A phase III randomized trial comparing RT with Chemo-RT for locally advanced nasopharyngeal cancer

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2006-11-014

OAAI

Meta-analysis of amifostine in radiotherapy (MAART): Preliminary analysis of 11 randomized clinical trials including 1,014 patients

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2006-11-015

PREAI

An exploratory analysis of the impact of age, performance status, and comorbidity on clinical outcomes in a randomized phase II trial of single agent gemcitabine, vinorelbine or docetaxel in patients with advanced non-small cell lung cancer who have poor performance status and/or are elderly

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

IF5.6

2006-11-010

PRE

Chemo-radiotherapy for stage III unresectable non-small cell lung cancer - long-term results of a prospective study

RESPIRATORY MEDICINE

IF3.1

2004-11-017

OAAI

A multicenter phase II study of the efficacy and safety of docetaxel plus cisplatin in Asian chemonaive patients with metastatic or locally advanced non-small cell lung cancer

RESPIRATORY MEDICINE

IF3.1

2003-07-012

OAAI

Design of a prognostic index score for metastatic nasopharyngeal carcinoma

EUROPEAN JOURNAL OF CANCER

IF7.1

2003-07-01102

PREAI

Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type

吉西他滨在未分化型转移性鼻咽癌中的应用

ANNALS OF ONCOLOGY

IF65.4

2002-01-01121

OAAI